Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:243-248
doi: 10.1161/hq0202.104274
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kandabashi, T.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kandabashi, T.
Right arrow Articles by Takeshita, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
Hazardous Substances DB
*HISTAMINE
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Chronic ischemic heart disease
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:243.)
© 2002 American Heart Association, Inc.


Vascular Biology

Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries

Tadashi Kandabashi; Hiroaki Shimokawa; Yasushi Mukai; Tetsuya Matoba; Ikuko Kunihiro; Keiko Morikawa; Masaaki Ito; Shosuke Takahashi; Kozo Kaibuchi; Akira Takeshita

From the Department of Cardiovascular Medicine (T.K., H.S., Y.M., T.M., I.K., K.M., AT) and Department of Anesthesiology (S.T.), Kyushu University Graduate School of Medical Sciences, Fukuoka; First Department of Internal Medicine, Mie Univsersity School of Medicine, Tsu, Japan (M.I.), and Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Japan (K.K.).

Address correspondence to Hiroaki Shimokawa, MD, PhD, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail shimo{at}cardiol.med.kyushu-u.ac.jp

Coronary artery spasm plays an important role in the pathogenesis of a wide variety of ischemic heart diseases. We have recently demonstrated that Rho-kinase plays a key role in the spasm in our porcine model. However, it remains to be elucidated whether Rho-kinase–mediated pathway also contributes to vasoconstriction of human arteries. From 15 patients who underwent coronary artery bypass operation, segments of isolated left internal thoracic arteries were obtained, and the endothelium was gently removed. Serotonin and histamine caused contractions, which were markedly inhibited by a specific Rho-kinase inhibitor, hydroxyfasudil. Western blot analysis showed that, during the serotonin-induced contractions, the extent of phosphorylation of myosin-binding subunit of myosin phosphatase (MBS, one of the major substrates of Rho-kinase) was significantly increased in the specimens. Hydroxyfasudil again significantly suppressed the serotonin-induced increase in MBS phosphorylation. There was a significant positive correlation between the extent of MBS phosphorylation and that of the serotonin-induced contractions and between hydroxyfasudil-sensitive components of the contractions and the extent of arteriosclerosis. These results indicate that Rho-kinase plays an important role in vascular smooth muscle contractions of arteriosclerotic human arteries, suggesting that Rho-kinase could be regarded as an important target for the treatment of arteriosclerotic vascular diseases in humans.


Key Words: signal transduction • Rho-kinase • human artery • vascular smooth muscle




This article has been cited by other articles:


Home page
J. Physiol.Home page
R. Lu, A. Alioua, Y. Kumar, P. Kundu, M. Eghbali, N. V. Weisstaub, J. A. Gingrich, E. Stefani, and L. Toro
c-Src tyrosine kinase, a critical component for 5-HT2A receptor-mediated contraction in rat aorta
J. Physiol., August 15, 2008; 586(16): 3855 - 3869.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Hizume, K. Morikawa, A. Takaki, K. Abe, K. Sunagawa, M. Amano, K. Kaibuchi, C. Kubo, and H. Shimokawa
Sustained Elevation of Serum Cortisol Level Causes Sensitization of Coronary Vasoconstricting Responses in Pigs In Vivo: A Possible Link Between Stress and Coronary Vasospasm
Circ. Res., September 29, 2006; 99(7): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. P. Woodsome, A. Polzin, K. Kitazawa, M. Eto, and T. Kitazawa
Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells
J. Cell Sci., May 1, 2006; 119(9): 1769 - 1780.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Loirand, P. Guerin, and P. Pacaud
Rho Kinases in Cardiovascular Physiology and Pathophysiology
Circ. Res., February 17, 2006; 98(3): 322 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. K. Surks, N. Riddick, and K.-i. Ohtani
M-RIP Targets Myosin Phosphatase to Stress Fibers to Regulate Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells
J. Biol. Chem., December 30, 2005; 280(52): 42543 - 42551.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. H. P. Hilgers and R. C. Webb
Molecular Aspects of Arterial Smooth Muscle Contraction: Focus on Rho
Experimental Biology and Medicine, December 1, 2005; 230(11): 829 - 835.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. M. Vicari, B. Chaitman, D. Keefe, W. B. Smith, S. G. Chrysant, M. J. Tonkon, N. Bittar, R. J. Weiss, H. Morales-Ballejo, U. Thadani, et al.
Efficacy and Safety of Fasudil in Patients With Stable Angina: A Double-Blind, Placebo-Controlled, Phase 2 Trial
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Shimokawa and A. Takeshita
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1767 - 1775.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Endo, H. K. Surks, S. Mochizuki, N. Mochizuki, and M. E. Mendelsohn
Identification and Characterization of Zipper-interacting Protein Kinase as the Unique Vascular Smooth Muscle Myosin Phosphatase-associated Kinase
J. Biol. Chem., October 1, 2004; 279(40): 42055 - 42061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Nagaoka, Y. Morio, N. Casanova, N. Bauer, S. Gebb, I. McMurtry, and M. Oka
Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L665 - L672.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. A. Wehrwein, C. A. Northcott, R. D. Loberg, and S. W. Watts
Rho/Rho Kinase and Phosphoinositide 3-Kinase Are Parallel Pathways in the Development of Spontaneous Arterial Tone in Deoxycorticosterone Acetate-Salt Hypertension
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1011 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Kawamura, K. Yokote, S. Asaumi, K. Kobayashi, M. Fujimoto, Y. Maezawa, Y. Saito, and S. Mori
High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 276 - 281.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Eto, K. Morishige, Y. Matsumoto, K. Obara, K. Nakayama, S. Takahashi, et al.
Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm
Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2209 - 2214.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Ogita, S. Kunimoto, Y. Kamioka, H. Sawa, M. Masuda, and N. Mochizuki
EphA4-Mediated Rho Activation via Vsm-RhoGEF Expressed Specifically in Vascular Smooth Muscle Cells
Circ. Res., July 11, 2003; 93(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Galle, A. Mameghani, S.-S. Bolz, S. Gambaryan, M. Gorg, T. Quaschning, U. Raff, H. Barth, S. Seibold, C. Wanner, et al.
Oxidized LDL and its Compound Lysophosphatidylcholine Potentiate AngII-Induced Vasoconstriction by Stimulation of RhoA
J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Seko, M. Ito, Y. Kureishi, R. Okamoto, N. Moriki, K. Onishi, N. Isaka, D. J. Hartshorne, and T. Nakano
Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle
Circ. Res., March 7, 2003; 92(4): 411 - 418.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Masumoto, M. Mohri, H. Shimokawa, L. Urakami, M. Usui, and A. Takeshita
Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina
Circulation, April 2, 2002; 105(13): 1545 - 1547.
[Abstract] [Full Text] [PDF]